All eligible to vote Principal Investigators (630) from EBMT full membership centres were invited to vote online for the nominated, endorsed and approved EBMT President-Elect and Working Party Chair candidates for 2025, in addition to approving the activity reports (President, Secretary and Treasurer).
Voting took place online from Tuesday 18 March 2025. The elections results were announced live at the General Assembly Meeting on Tuesday 1 April (07:45 am CET), during the 51st Annual Meeting of the EBMT.
Please see the results of this online election below:
EBMT President-Elect
| 272 votes tallied and 2 abstentions | Votes | Percentage |
|---|---|---|
| Ibrahim Yakoub-Agha | 155 | 56.99% |
| John Snowden | 117 | 43.01% |
“I am deeply honoured and grateful to be elected as President-Elect of the EBMT.
Thanks to the exceptional leadership of past and current EBMT presidents, our society has become a global leader in cellular therapy.As President, I will focus on streamlining our organization, strengthening its scientific impact, and securing financial sustainability. I will also advocate for regulatory improvements and foster stronger collaboration with industry and healthcare partners to make innovative therapies more accessible.
Together, we will ensure EBMT remains a transparent, dynamic force that delivers real value to our members and advances patient care across Europe and beyond.” Ibrahim Yakoub-Agha
EBMT Working Party Chairs
| 258 votes tallied and 16 abstentions | Votes | Percentage |
|---|---|---|
| Maria Ester Bernardo | 258 | 99.22% |
| 261 votes tallied and 13 abstentions | Votes | Percentage |
|---|---|---|
| Olaf Penack | 261 | 98.85% |
"It is a great honour for me to be elected as Transplant Complications Working Party (TCWP) chairperson.
Our mission is to perform research and education on complications after all cellular therapies to lay the foundation for an optimal clinical management that ensures optimal survival and quality of life.I envision the following central aims of TCWP during the upcoming years:
• to improve the scientific and educational output and quality by expanding the collaboration with the other EBMT Working Parties and with the EBMT Nurses Group
• to strengthen partnerships with international societies as well as with potential investors in the field
• to intensify the work with patient organizations and to implement the documentation of patient-reported outcomes within EBMT." Olaf Penack
EBMT Activity Reports and Bylaw Amendment
In addition to voting online for the nominated candidates, PIs were also asked to approve the President's, Secretary's and the Treasurer's reports and the Bylaw Amendment Approval of Articles 8, The Treasurer and 9, Working Parties, in advance of the Annual General Assembly Meeting 2024.
EBMT President's Activity Report 2024
| Yes - I approve the President's Activity Report 2024 | 252 votes (98.44%) |
|---|---|
| No - I reject the President's Activity Report 2024 | 4 votes (1.56%) |
| 256 votes tallied and 18 abstentions |
EBMT Treasurer's Annual Report for 2024
| Yes - I approve the Treasurer's Annual Report for 2024 | 239 votes (98.35%) |
|---|---|
| No - I reject the Treasurer's Annual Report for 2024 | 4 votes (1.65%) |
| 243 votes tallied and 31 abstentions |
EBMT Secretary's Annual Report for 2024
| Yes - I approve the Secretary's Annual Report for 2024 | 251 votes (98.43%) |
|---|---|
| No - I reject the Secretary's Annual Report for 2024 | 4 votes (1.57%) |
| 255 votes tallied and 19 abstentions |
Bylaw Amendment Approval - formally establish the JACIE Working Party (WP) as part of EBMT's existing WP structure. The appointment of Lynn Manson as Chair of the JACIE WP until the end of her mandate in 2026
| Yes - I approve the amendment | 239 votes (95.22%) |
|---|---|
| No - I reject the amendment | 12 votes (4.78%) |
| 251 votes tallied and 23 abstentions |
"On behalf of the JACIE community, I wish to thank EBMT colleagues for supporting JACIE in attaining Working Party status.
This change will enable JACIE to collaborate proactively with established Working Party colleagues to promote our quality assurance activities, and identify opportunities to work together. With ready access to registry data, we will look to show objectively the benefit to patients, and staff, of receiving and delivering cellular therapies within a controlled environment.
Aspects of JACIE assurance activities that do, and do not, add value will be more easily identified and shared, leading to improvement opportunities.
It is my privilege to be the inaugural Chair of the JACIE Working Party and to facilitate our transition from Committee status.
I remain committed to quality assurance within clinical transplantation and cellular therapies after 24 years of working in cell collection, therapeutic apheresis and clinical transfusion medicine, and am delighted to accept this new challenge." Lynn Manson
Outgoing Board Members
We would like to thank the following outgoing Board Members for their support and commitment to the Scientific Council and Board of Association during their mandates:
